One Nucleus is partnering with Domainex for an upcoming webinar exploring polymer nanodiscs in membrane protein structural biology.
Public source
Publisher name
Public post
𝐃𝐞𝐬𝐩𝐢𝐭𝐞 𝐫𝐞𝐩𝐫𝐞𝐬𝐞𝐧𝐭𝐢𝐧𝐠 𝐭𝐡𝐞 𝐭𝐚𝐫𝐠𝐞𝐭 𝐨𝐟 𝐦𝐚𝐧𝐲 𝐚𝐩𝐩𝐫𝐨𝐯𝐞𝐝 𝐦𝐞𝐝𝐢𝐜𝐢𝐧𝐞𝐬, 𝐦𝐞𝐦𝐛𝐫𝐚𝐧𝐞 𝐩𝐫𝐨𝐭𝐞𝐢𝐧𝐬 𝐫𝐞𝐦𝐚𝐢𝐧 𝐚𝐦𝐨𝐧𝐠…
Company
One Nucleus
Connecting Life Sciences
- Industry
- Biotechnology Research
- Location
- Cambridge, GB
- Company size
- 11–50 employees
About One Nucleus
One Nucleus is a not-for-profit Life Sciences & Healthcare membership organisation headquartered in Cambridge. We support institutions, companies and individuals in the Life Sciences sector providing local, UK-wide and international connectivity. Through providing the local, UK-wide and international connectivity, One Nucleus seeks to enable our members to maximise their performance. This support helps them achieve, or better still exceed, the goals they have set for themselves. Biomedical and Healthcare R&D have always been impactful in driving social and economic progress. In an increasingly outsourced, collaborative and multi-disciplinary sector, bringing the best people together is key to translating great innovation into great products that markedly improve patient outcomes and drive economic development. Attracting and enabling the best people to engage with is at the heart of the One Nucleus team ethos and what we continually strive to deliver.
See moreLatest activity
Latest activity from One Nucleus
12 signals
Presence & Recognition
One Nucleus announced its first two speakers for the upcoming BioWednesday Breakfast in Cambridge, Emily Pilkington and Simon Amies.
People
One Nucleus welcomed Syplex Ltd to the network.
Presence & Recognition
One Nucleus is hosting an upcoming webinar featuring Jim Reid discussing a novel polymer nanodisc technology for improving membrane protein yield, stability, and solubility.
Discover more
Similar signals
Similar public activity from other companies.
Presence & Recognition
Domainex
Domainex is collaborating with One Nucleus for an upcoming webinar introducing Domainex's next-generation polymer nanodisc platform PureDisc.
Partnerships
Instruct-ERIC
Instruct-ERIC is accepting applications for funded access to structural biology technologies from academic and commercial scientists from Instruct Member Countries and organisations.
Partnerships
SpiroChem
SpiroChem and ITM Isotope Technologies Munich SE announced a strategic drug discovery collaboration to advance a novel radiopharmaceutical candidate for ITM's pipeline.
Partnerships
BioChannel Partners Ltd
BioChannel Partners Ltd announced that Novilytic has developed innovative processes to simplify and accelerate bioanalysis for protein-based pharmaceuticals.
Partnerships
NeoBiotechnologies | Recombinant Monoclonal Antibodies for Cancer Research